Serina Therapeutics, Inc. (SER)
1.46
-0.19
(-11.52%)
USD |
NYAM |
Nov 06, 10:05
Serina Therapeutics Price : 1.46 for Nov. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 05, 2026 | 1.68 | 1.71 | 1.61 | 1.65 | 21202.00 |
| Nov 04, 2026 | 1.70 | 1.80 | 1.626 | 1.69 | 39634.00 |
| Nov 03, 2026 | 1.79 | 1.85 | 1.67 | 1.83 | 30590.00 |
| Nov 02, 2026 | 1.92 | 2.00 | 1.85 | 1.85 | 38993.00 |
| Oct 30, 2026 | 1.47 | 2.55 | 1.47 | 1.94 | 155108.0 |
| Oct 29, 2026 | 1.51 | 1.99 | 1.46 | 1.89 | 66349.00 |
| Oct 28, 2026 | 1.28 | 1.70 | 1.28 | 1.64 | 28263.00 |
| Oct 27, 2026 | 1.38 | 1.80 | 1.38 | 1.67 | 172034.0 |
| Oct 26, 2026 | 1.63 | 1.750 | 1.588 | 1.71 | 38290.00 |
| Oct 23, 2026 | 1.73 | 1.76 | 1.65 | 1.65 | 8002.00 |
| Oct 22, 2026 | 1.73 | 1.80 | 1.72 | 1.76 | 51258.00 |
| Oct 21, 2026 | 1.67 | 1.78 | 1.63 | 1.77 | 39787.00 |
| Oct 20, 2026 | 1.64 | 1.735 | 1.63 | 1.66 | 42126.00 |
| Oct 19, 2026 | 1.75 | 1.81 | 1.65 | 1.65 | 22056.00 |
| Oct 16, 2026 | 1.72 | 1.83 | 1.72 | 1.72 | 15667.00 |
| Oct 15, 2026 | 1.71 | 1.94 | 1.71 | 1.79 | 27436.00 |
| Oct 14, 2026 | 1.80 | 1.838 | 1.71 | 1.71 | 46259.00 |
| Oct 13, 2026 | 1.92 | 1.974 | 1.780 | 1.82 | 26333.00 |
| Oct 12, 2026 | 2.01 | 2.01 | 1.90 | 1.94 | 132242.0 |
| Oct 09, 2026 | 1.99 | 2.05 | 1.99 | 2.00 | 22349.00 |
| Oct 08, 2026 | 2.01 | 2.05 | 1.99 | 2.01 | 59287.00 |
| Oct 07, 2026 | 2.04 | 2.08 | 2.01 | 2.01 | 13183.00 |
| Oct 06, 2026 | 2.025 | 2.080 | 2.016 | 2.04 | 8719.00 |
| Oct 05, 2026 | 2.10 | 2.10 | 1.965 | 2.04 | 25270.00 |
| Oct 02, 2026 | 1.98 | 2.10 | 1.952 | 1.96 | 15566.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 57.37 |
| Oncolytics Biotech, Inc. | 0.4545 |
| Sangamo Therapeutics, Inc. | 0.114 |
| Sarepta Therapeutics, Inc. | 17.80 |
| Anixa Biosciences, Inc. | 3.02 |
Price Related Metrics
| PEG Ratio | -0.0027 |
| Price to Book Value | 1.980 |
| Earnings Yield | -128.6% |
| Market Cap | 37.08M |
| PEGY Ratio | -0.0027 |